pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,900 catalysts · 5,256 phase readout · 2,298 8k filing · 343 pdufa · 255 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,298
  • pdufa343
  • earnings255
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT07362264: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.. Phase: PHASE1. Conditions: Liver Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07480564: Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome

Sponsor: Taysha Gene Therapies, Inc.. Phase: PHASE3. Conditions: Rett Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07572409: Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study

Sponsor: manxiaxia. Phase: NA. Conditions: Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06503809: Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT07006532: Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Sponsor: Shahid Beheshti University of Medical Sciences. Phase: NA. Conditions: Kidney Transplant Rejection

full page →ctgov ↗
›COMPLETEDphase readoutNCT05927532: Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study

Sponsor: Mozarc Medical US LLC. Phase: NA. Conditions: End Stage Renal Failure on Dialysis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07499232: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Crohn Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07003698: Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block

Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Laparoskopic Cholecystectomy, Recto Intercostal Nerve Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT05169398: EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Malignant Biliary Obstruction

full page →ctgov ↗
›COMPLETEDphase readoutNCT04781621: Foundational Ingredients of Robotic Gait Training for People With Spinal Cord Injury During Inpatient Therapy

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Spinal Cord Injuries

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03711214: Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Sjogren's Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04829604: ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Sponsor: Ambrx, Inc.. Phase: PHASE2. Conditions: HER2 Positive Metastatic Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05451004: SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

Sponsor: Canadian Cancer Trials Group. Phase: PHASE3. Conditions: Oropharyngeal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07286604: Ivermectin Repurposed for the Treatment of PKDL

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh. Phase: EARLY_PHASE1. Conditions: Post Kala Azar Dermal Leishmaniasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05235204: Early Foley Catheter Removal After Diverticular Colovesical Fistula Repair

Sponsor: Karim Alavi. Phase: NA. Conditions: Colovesical Fistula

full page →ctgov ↗
›COMPLETEDphase readoutNCT04371484: Proposal of a Method Using the PMSI and SNIIRAM National Databases to Estimate the Frequency of Physical Abuse and to Identify th Eassociated At-risk Situations and Consequences in Children Aged 0 to 5 Years in France

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Child Abuse

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03921684: Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

Sponsor: Baruch Brenner. Phase: PHASE2. Conditions: Rectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07319052: β-Alanine for Kickboxing Anaerobic Performance

Sponsor: Salih ÇABUK. Phase: NA. Conditions: Athletic Performance Enhancement (Kickboxing), Anaerobic Performance, Strength Endurance, Neuromuscular Power, Nutritional Supplementation (β-Alanine)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05610852: Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Sponsor: Case Comprehensive Cancer Center. Phase: NA. Conditions: Prostate Adenocarcinoma, Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06372249: A Clinical Trial of Soluble Fiber for Asthma

Sponsor: Phoenix Children's Hospital. Phase: PHASE2. Conditions: Asthma in Children

full page →ctgov ↗
›TERMINATEDphase readoutNCT05318638: Soft-robotic Glove Support of High-demand Tasks

Sponsor: Roessingh Research and Development. Phase: NA. Conditions: Neuromuscular Diseases, Sarcopenia

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06023238: Knee Prosthetic Joint Infection Antibiotic Elution

Sponsor: University of Pittsburgh. Phase: . Conditions: Prosthetic-joint Infection, Arthroplasty Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT07239258: The Effects of Mir Shakeel Teleintegrated Therapy Plan in Patients Undergoing Total Knee Arthroplasty

Sponsor: Lincoln University College. Phase: NA. Conditions: Total Knee Anthroplasty, Total Knee Arthroplasty Recovery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05757778: Split Chest Breast Neurotization

Sponsor: NYU Langone Health. Phase: NA. Conditions: Breast Implant; Complications

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07123285: Effect of Photobiomodulation on Healing of Venous Leg Ulcers

Sponsor: University of Nove de Julho. Phase: NA. Conditions: Venous Disease, Venous Insufficiency (Chronic)(Peripheral), Venous Insufficiency of Leg, Venous Leg Ulcer (VLU), Venous Leg Ulcer, Venous Hypertension Ulcers, Varicose Ulcers, Varicose Ulcer of Lower Limb

full page →ctgov ↗
›RECRUITINGphase readoutNCT05733585: Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Sponsor: IRCCS San Raffaele. Phase: . Conditions: Hemostatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT07534085: Effects of a Structured Physical Activity Program on Balance and Functional Performance in Children With Down Syndrome

Sponsor: Ankara University. Phase: NA. Conditions: Down Syndrome (DS), Balance Assessment, Physical Activities, Yoga, Rehabilitation

full page →ctgov ↗
›RECRUITINGphase readoutNCT05806645: UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

Sponsor: University of Alberta. Phase: NA. Conditions: Acute Kidney Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07118345: Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial

Sponsor: Xuanwu Hospital, Beijing. Phase: NA. Conditions: Stroke, Ischemic, Cerebral Edema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06578195: ASSESS ALL ALS Study

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix. Phase: . Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT02526095: The French EsoGastricTumours Data Base

Sponsor: University Hospital, Lille. Phase: . Conditions: Esophageal Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07351695: Assessment of Nutritional Status Using Mid-Upper Arm Circumference Z-Score in Children With Cerebral Palsy

Sponsor: Muğla Sıtkı Koçman University. Phase: . Conditions: Cerebral Palsy (CP), Malnutrition in Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT04888039: Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06603077: A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

Sponsor: Avalo Therapeutics, Inc.. Phase: PHASE2. Conditions: Hidradenitis Suppurativa

full page →ctgov ↗
›AVAILABLEphase readoutNCT07310277: Expanded Access to ABBV-706

Sponsor: AbbVie. Phase: . Conditions: Small Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03049475: Pathophysiology of Acute Pain in Patients With Sickle Cell Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Sickle Cell Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07035275: Effect of Patient-Anesthesiologist Gender Concordance and Analgesia Method on Postoperative Pain in Mastectomy Patients

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Breast Cancer, Mastectomy, Postoperative Pain, Analgesic Use

full page →ctgov ↗
›RECRUITINGphase readoutNCT06315075: Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial

Sponsor: Haukeland University Hospital. Phase: NA. Conditions: Self-harm, Suicidal Ideation, Suicide and Self-harm

full page →ctgov ↗
›COMPLETEDphase readoutNCT06633757: Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance

Sponsor: ReCode Therapeutics. Phase: PHASE1. Conditions: Primary Ciliary Dyskinesia (PCD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07505212: Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals.

Sponsor: Prairie View A&M University. Phase: NA. Conditions: Obesity (Disorder)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05305781: Study of the Determinants of Emergency Dialysis in Reunion Island

Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Dialysis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583381: A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases

Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: Colorectal Liver Metastasis, Liver Neoplasms, Colorectal Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT06513065: Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Sponsor: University of Southampton. Phase: PHASE3. Conditions: Pseudomyxoma Peritonei

full page →ctgov ↗
›RECRUITINGphase readoutNCT05868265: A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05848765: Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06722365: Characterization of Fetal Lung With Quantitative Ultrasound

Sponsor: University of Wisconsin, Madison. Phase: . Conditions: Respiratory Complication, Fetal Lung Imaging

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05780567: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04708067: Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07318467: Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

Sponsor: Cairo University. Phase: NA. Conditions: Post Partum Hemorrhage

full page →ctgov ↗
›RECRUITINGphase readoutNCT05666167: Expanding Exercise Programming for Veterans Through Telehealth

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Arthritis

full page →ctgov ↗
← prev
page 87 of 158
next →